"10.1371_journal.pone.0085741","plos one","2014-02-26T00:00:00Z","Rezwan Ghassemi; Sridar Narayanan; Brenda Banwell; John G Sled; Manohar Shroff; Douglas L Arnold; on behalf of the Canadian Pediatric Demyelinating Disease Network","Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada; The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada; The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America","Conceived and designed the experiments: RG SN BB JGS MS DA. Performed the experiments: RG. Analyzed the data: RG. Contributed reagents/materials/analysis tools: BB DA. Wrote the paper: RG BB SN DA.","Ms. Ghassemi, Dr. Sled, Dr. Shroff and Dr. Arnold have declared that no competing interests exist. Dr. Narayanan has received personal compensation for consulting activities from NeuroRx Research, Teva Innovation Canada, and Biogen Idec Canada. Dr. Banwell serves as an advisor, without financial compensation, for clinical trials in pediatric multiple sclerosis for Biogen-Idec, Novartis, Eli Lilly, and Sanofi-Aventis. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2014","02","Rezwan Ghassemi","RG",7,FALSE,6,1,1,4,TRUE,TRUE,TRUE,1,"7",TRUE
